These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1205 related items for PubMed ID: 15780165
1. Prostate biopsy: who, how and when. An update. Djavan B, Milani S, Remzi M. Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165 [Abstract] [Full Text] [Related]
5. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H. J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340 [Abstract] [Full Text] [Related]
6. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M. J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484 [Abstract] [Full Text] [Related]
8. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade. Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS. J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706 [Abstract] [Full Text] [Related]
10. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. Noguchi M, Stamey TA, McNeal JE, Yemoto CM. J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712 [Abstract] [Full Text] [Related]
11. No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam). Roobol MJ, van der Cruijsen IW, Schröder FH. Urology; 2004 May; 63(5):892-7; discussion 897-9. PubMed ID: 15134973 [Abstract] [Full Text] [Related]
15. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC. Cancer; 2003 Dec 01; 98(11):2344-50. PubMed ID: 14635068 [Abstract] [Full Text] [Related]
19. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. Noguchi M, Stamey TA, McNeal JE, Yemoto CM. J Urol; 2001 Jul 01; 166(1):104-9; discussion 109-10. PubMed ID: 11435833 [Abstract] [Full Text] [Related]
20. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Campos-Fernandes JL, Bastien L, Nicolaiew N, Robert G, Terry S, Vacherot F, Salomon L, Allory Y, Vordos D, Hoznek A, Yiou R, Patard JJ, Abbou CC, de la Taille A. Eur Urol; 2009 Mar 01; 55(3):600-6. PubMed ID: 18597923 [Abstract] [Full Text] [Related] Page: [Next] [New Search]